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New ion fragmentation technologies—electron capture dissociation (ECD) and electron-
transfer dissociation (ETD)—are based on interaction of multiply charged polypeptides with
either free electrons (ECD) or anionic species (ETD). After initial difficulties, these ECD/ETD
(ExD) technologies are now being increasingly implemented in high-throughput proteomics
work. This critical analysis presents arguments for the combined use of ExD with the
conventional low-energy collisional excitation CID/CAD (CxD). It is argued that the database
search, a key technology in MS/MS-based proteomics, is vulnerable with respect to the
incomplete sequence information obtainable with either of the techniques, peptide MS/MS
homology being a major complicating factor. De novo sequencing is viewed as the only
adequate answer to this challenge and it can be achieved only with combined use of ExD and
CxD. The payoff in the form of additional sequence information is projected to exceed the costs
of such implementation. The greatest impact of combining ExD and CxD is expected in
high-resolution instruments. (J Am Soc Mass Spectrom 2008, 19, 753–761) © 2008 American
Society for Mass SpectrometryFor several years after the emergence of electroncapture dissociation (ECD) a decade ago [1] it hasnot been clear whether this technology could be
used in high-throughput analysis. Originally, ECD has
been available only in Fourier transform ion cyclotron
resonance (FT-ICR) mass spectrometry, where the typ-
ical reaction time with electrons was 10 s and integra-
tion of at least 10 acquisitions was needed for achieving
acceptable signal-to-noise ratios [2]. Switching from
filament-based electron sources to indirectly heated
dispenser cathodes reduced the irradiation time to
milliseconds and improved the fragment collection ef-
ficiency [3, 4]. However, the issue of low signal-to-noise
ratios remained and, since a single spectrum acquisition
in FT-ICR lasts several hundred milliseconds or longer,
integration of several scans was a severe throughput
limitation. Despite a few reports on successful on-line
implementation [5–7], ECD remained essentially an
off-line technique. Later, a combination of optimized
FT-ICR cell design, on-axis filament arrangement and
low-energy gated trapping allowed one to achieve
good-quality ECD mass spectra in a single acquisition
[4], which opened a way for high-throughput analysis.
Several groups worked on implementation of ECD in
radiofrequency trapping devices, with encouraging first
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doi:10.1016/j.jasms.2008.03.007results [8, 9]. However, the real breakthrough in making
ECD-type technology available to a broader circle of
researchers came with the discovery of efficient ion–ion
reactions with radical anions termed electron-transfer
dissociation (ETD) [10]. The evidence of that is the
string of recent high-profile publications [11–14]. In
view of this success, the role of ECD/ETD (which we
shorten to ExD) in mass spectrometry deserves a sepa-
rate discussion. To initiate such a discussion, we chose
as a central topic the relationship between the tradi-
tional collisional excitation techniques collisionally ac-
tivated dissociation (CAD)/collision-induced dissocia-
tion (CID) (CxD) and ExD in the most frequent in the
proteomics task of peptide sequence analysis. Is there a
conflict, competition, or cooperation between these two
groups of fragmentation techniques? Will they evolve
hand by hand or will one of them become dominant
and the other one doomed to extinction? Below we try
to address these issues, in no way pretending to cover
all relevant aspects.
Discussion
Is CAD/CID Alone Sufficient?
If CxD could solve all analytical problems encountered
in mass spectrometry, no additional/alternative frag-
mentation technique would be needed. The reasons that
CxD is insufficient in proteomics have recently been
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One is that CxD does not cleave nearly all the required
bonds to derive full information on primary structure of
a polypeptide [16]. The other is that, even when all
peptide bonds are cleaved, the obtained information on
the fragment masses is still insufficient to uniquely
identify the sequence and its modifications. Let us
investigate these reasons more closely.
To understand why CxD does not in the general case
cleave all peptide bonds, consider the distribution of
CxD peptide y-ion fragment abundances (Figure 1a).
These abundances are obtained in fragmentation in a
linear ion trap of doubly charged tryptic peptides
[17]—that is, where both the size of the molecules
(about 10 residues on average) and the ratio between
the number of ionizing protons (two) and strongly basic
groups (one) is advantageous for obtaining abundant
backbone fragmentation [18, 19]. Even in that almost
ideal situation, however, the fragment abundances rap-
idly fall off, with the fifth (Figure 1a) or sixth (Figure 1b)
most abundant fragment being on average 10 times less
intense than the fragment with the highest abundance.
There is a slight anomaly in the ratio between the first
two peaks in Figure 1a, which is eliminated (Figure 1b)
when proline-containing peptides are disregarded, along
with the special case of yn2 cleavage. A 13-residue
peptide requires 12 backbone cleavages for complete
primary structure determination; it can be deduced
that, if the trend in Figure 1 continues, the least abun-
dant of these cleavages will on average be 100 times less
abundant than the most abundant fragment. Therefore,
if the signal-to-noise (S/N) ratio of the precursor ion
upon isolation before MS/MS is less than 200:1, one
cannot in general expect a complete cleavage pattern
(assuming S/N 2:1 as a threshold for fragment detec-
tion). The latter estimate is done based on 100% conver-
sion efficiency of the precursor ions into backbone
fragments, which is an idealization (only half of the
Figure 1. (a) distribution of normalized averag
doubly protonated tryptic peptides from the
exponential fit. (b) Same as (a) except that all p
fragments are not considered.total ion abundance in MS/MS spectra obtained in anion trap can be attributed to b- or y-ions [18]. Taking
into account less than 100% fragment detection effi-
ciency and the fact that singly charged fragments produce
in induced-current detectors (the type used in Fourier
transformmass spectrometry) half as strong a signal as the
same number of doubly charged precursors, we conclude
that S/N 1000:1 is a realistic value of the lowest signal
required for complete sequencing by CxD of moderately
large doubly charged tryptic peptides.
The requirement of the high signal abundance is a
significant analytical limitation of CxD. The cause of
this limitation is the “mobile proton” mechanism of
CxD backbone cleavages [19] that is dominant in mul-
tiply protonated tryptic peptides with one strongly
basic group. The simplest model quantitatively describ-
ing the “mobile proton” fragmentation [20] suggests
that the cleavage probability after an amino acid residue
is determined by the probability for a proton to reside
on the respective carbonyl, which in turn is determined
by the carbonyl basicity GB of this residue. Within that
model, the “dynamic range” of CxD cleavages is deter-
mined by the difference GBmax between the maximum
and minimum GB values divided by kTint, where Tint is
the internal temperature. Thus higher Tint should nar-
row the dynamic range. Such an increase can be
achieved by more energetic ion-neutral collisions. How-
ever, higher collision energies usually lead to a larger
scattering and often result in a decrease in the efficiency
of fragment collection and thus in an overall loss of
sensitivity.
In the absence of mobile protons, different CxD
mechanisms prevail [21], in which carbonyl basicities
play a less important role compared to the chemical
activity of side chains. The “dynamic range” of such
cleavages can be even greater than that in the presence
of a mobile proton [18].
Limited CxD efficiency in sequencing of polypep-
tides is also caused by a frequent overlap of the masses
n abundances in 15,000 CAD mass spectra of
dCAD database [17]. The curve is the best
des containing proline are discarded, and yn2e y-io
Swe
eptiof N-terminal and C-terminal fragments. Such an over-
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The overlap does not have to be precise; even partial
fusion of isotopic distributions can confuse computer
algorithms performing peak assignment. Higher reso-
lution and mass accuracy always reduce the risk of an
error, but are only a partial cure since theoretical masses
of b- and y-ions can be as close as desired and even
identical. Thus the risk of an overlap is always present
and it grows with the molecular mass.
Another important factor influencing CxD efficiency
is that low-energy collisions do not allow one to distin-
guish between the isomeric Leu/Ile (Xle) residues.
Together these residues account for 1/6 of all amino
acids found in natural proteins, which means that any
peptide more than four residues long more likely than
not contains at least one Xle residue. The amount of Xle
isoforms (groups of tryptic peptides with identical
sequences except for Leu/Ile permutation) in protein
databases is very large; in our experience such isoforms
are one of the main causes of wrong peptide assignment
in a MS/MS database search. Note that neither im-
proved CxD efficiency nor extremely high mass accu-
racy is capable of resolving Xle isoforms; only second-
ary, side-chain fragmentation resulting into d- and
w-ions can help.
Finally, many posttranslational modifications in CxD
are labile in the gas phase, such as Ser, Thr, and His
phosphorylations as well as N- and particularly O-
glycosylations. This makes CxD unsuitable for their
characterization without chemical derivatization.
Complementarity of ExD and CxD
In ExD, the NOC bond is cleaved as opposed to the
CON bond in CxD, but this is not the main reason for
the complementarity of these two techniques. To be truly
complementary, ExD should preferentially cleave at dif-
ferent residues than CxD. Previously, statistical analysis
has shown that this is indeed the case [23]; the conclusion
is now confirmed with an updated and extended data-
Figure 2. Amino acid preferences in 15,000 t
same peptides as in Figure 1. Compared to Savits
were added.base. Figure 2 demonstrates these updated propensitiesfor CAD and ECD cleavages in a color-codedmode. There
is no statistical correlation between the amino acid pref-
erences in these two techniques (correlation coefficient is
close to zero), and for the same peptide the site of themost
abundant cleavage in CxD is usually shifted with respect
to the similar site in ExD [23].
The “dynamic range” of ExD mass spectra is nar-
rower than that of CxD (Figure 3). Since the internal
temperatures in ExD are less than those in CxD, the
narrower dynamic range means in a simple quantitative
model a smaller Gmax value. The nature of the “G”
values responsible for the cleavage frequencies in ExD
is not yet understood. They are unlikely to relate to
backbone amide basicities [20] and more likely to hy-
drogen atom affinities. Empirically, the best correlation
mass spectra CAD and ECD obtained for the
al. [23], the database was extended, data for Met
Figure 3. Distribution of normalized average z-ion abundances
in 15,000 ECD mass spectra obtained for the same peptides as inandem
ki etFigure 1. The curve is the best exponential fit.
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hydrophobicity indexes [24], but this correlation has so
far found no simple explanation.
The advantage of ExD in narrow dynamic range of
fragmentation compared to CxD increases its relative
importance when molecular mass increases. Thus ExD
is particularly suitable for fragmentation of larger
polypeptides, including intact proteins [25–27].
The ability of ExD to differentiate between Ile and
Leu residues via secondary fragmentation in radical z•
ions increases its utility as a complement to CxD
[28–29]. Finally, the “soft” character of ExD cleavages
makes this technique suitable for analysis of labile
posttranslational modifications [30–32]. The comple-
mentarity of CxD and ExD is also reflected in the “small
fragment” area. Whereas CxD produces immonium
ions that are characteristic of the presence of certain
amino acid in sequence, ExD gives few such ions but
instead produces losses of neutral particle from the
charge-reduced molecular species that are amino acid
specific [33].
Can ExD Replace CxD?
There is an obvious practical advantage in using just
one fragmentation technique as a universal MS/MS
tool, provided this tool satisfies analytical needs. Since
it is unlikely that CxD (at least in its currently dominant
form) would ever be able to replace ExD, let us consider
the consequences of replacing CxD with ExD. The
instrumental complexity and cost are likely to increase
because CxD is easier to implement on most instru-
ments than ExD. In shotgun proteomics, trypsin will no
longer remain the most advantageous enzyme for pep-
tide production because tryptic peptides tend to be
preferentially doubly charged in electrospray ioniza-
tion, which is a disadvantage for ExD where efficiency
Figure 4. MS/MS spectra of a doubly protonat
FLQPVQK (top) and FIPINAGK (bottom) obtained wdiminishes because of partial charge neutralization [34].
Of course, ExD is not applicable to singly charged ions
or to negatively charge species (electron excitation
dissociation, EED [35], and electron detachment disso-
ciation, EDD [36], are special cases). Trypsin can of
course be replaced by Lys-C or Arg-C [14, 37], although
these enzymes tend to be less available. Importantly,
Lys-C and Arg-C produce fewer peptides than trypsin,
which reduces the sample complexity but may decrease
the detection probability for low-abundance proteins.
CxD of larger peptides produced by Arg-C and Lys-C is
relatively less informative than CxD of smaller tryptic
peptides, and thus the enzyme change will negatively
affect the ability of this technique to complement ExD
data. ExD seems to be sensitive to charge density in
polypeptides, with efficiency dropping off with m/z
faster than that in CxD [34]. Last but not least, most
search engines are optimized for CxD MS/MS spectra
and are less effective in processing ExD mass spectra.
One should also bear in mind that, whereas masses
of b and y fragments in CxD are well-defined, masses of
c- and z-ions in ExD can be 1 Da lighter or heavier,
respectively, because of the extensive hydrogen rear-
rangement [2, 38, 39]. This effect reduces the certainty of
fragment assignment from ExD-only mass spectra,
which can be particularly challenging in de novo se-
quencing [16].
Thus we do not believe that the ExD-only approach
is any more advantageous than the CxD-only regime. In
our opinion, ExD and CxD technologies are best when
implemented together, so that their complementarity
can be exploited in the best possible manner.
Combined Use of CxD and ExD
To appreciate the importance of complementary infor-
mation, consider the CAD mass spectrum in Figure 4a.
eptide with fragments assigned to the sequenceed p
ith: (a) CAD; (b) ECD.
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using a 20 mDa mass accuracy window for fragment
masses and 3 ppm for molecular masses, it received
identical scores for both FLQPVQK and FIPINAGK
peptides because both sequences are equally well ex-
plained by the MS/MS spectrum. Observe how some
fragments are fitted as y-ions in one case and b-ions in
the other case. However, the ECD spectrum (Figure 4b)
shows a clear preference for the FLQPVQK sequence.
Although technically the only difference in the back-
bone cleavage in ECD compared to CAD is the presence
of the C-terminal cleavage to proline, this along with
the two w-ions confirming the glutamine and leucine
assignments [40] is enough to make a reliable distinc-
tion between the two sequences.
This example illustrates the nonlinear effect on un-
certainty reduction of additional sequence information.
Every additional piece of sequence information is of an
increasing value, and the reverse is also true. For
instance, in high-performance de novo sequencing, full
sequences are far more reliable than sequences derived
with “gaps,” even small gaps two residues long [16].
The nonlinear effect of complementary sequence infor-
mation is worth remembering when assessing the cost/
benefit balance of using two fragmentation techniques
versus one.
Is De Novo Sequencing Really Needed?
The benefits of complementary sequence information
are particularly obvious in de novo sequencing [41].
However, there is a regrettably widespread perception
that de novo sequencing of polypeptides is no longer
required, given that a database search is very reliable
and the volume of databases is rapidly expanding. In
our opinion, the last two statements are in contradiction
because the more limited the database is, the less
information is required to identify a unique match in
that database. However, finding a unique match in a
limited database is not a guarantee of the validity of
that match, and artificial reduction of the database
size to “increase” the search validity is opposed by
database search experts [42]. Below we argue that
only de novo sequencing can guarantee error-free
sequence identification.
MS/MS Peptide Homology
It is sometimes argued that CxD alone can identify
peptide with any desirable certainty. There is no ques-
tion that beautiful examples of such identification can
be demonstrated. Proteomics is, however, a game of
large numbers. When a significant amount of datasets
just barely make it above the identification threshold
(which is often the case), it is extremely difficult to
provide the error-free status. Even 99.9% certainty in
protein identification gives a few false positives when
several thousand of proteins are identified. A realitycheck is therefore advised when an exceptionally low
false discovery rate is reported.
One of the serious limitations of the database search
approach is peptide MS/MS homology, which in this
discussion is not equivalent to sequence homology (the
homology used in BLAST search), but relates to the fact
that mass lists of MS/MS fragments of peptides with
different sequences may look similar or even identical
(see Figure 4a for an example). For instance, all peptides
are MS/MS homologs of their own reversed sequences,
given that bn ions of the forward sequence coincide with
(yn=  H2O) ions of the reversed sequence and yn= ions
of the forward sequence have the same masses as (bn 
H2O) ions [43] of the reversed sequence. The larger the
database, the larger is the chance of matching a ho-
molog. The ultimate database includes all possible
sequences and search in such a database is equivalent to
de novo sequencing.
To illustrate the widespread appearance of peptide
MS/MS homology, consider the results of a Mascot
search of MS/MS data on peptides from the whole
proteome of the human cell lines A431 performed in our
lab some time ago [44]. Matrix Science warns against
narrowing taxonomy in Mascot searches [42] and thus it
may be prudent, as a first step of analysis, to perform a
search in the full database for all species. Such a search
may reveal the presence of, for example, Mycoplasma
(between 5 and 35% of cell cultures in current use are
probably infected with mycoplasmas [45]). The search
in the full NCBI database gave a single, unique hit (with
any score) for only 3% of MS/MS queries that gave any
hit at all, and even narrowing the taxonomy to human-
only gave more than one hit in 46% of the cases (Figure 5).
Many MS/MS datasets gave repetitive, same-score top
hits: 64% of queries in all-NCBI search and 20% in
human-only search yielded different peptide sequences
with the same top score (Figure 6).
Homological hits, in turn, come in two kinds. When
an MS/MS spectrum receives a number of nonidentical
sequence assignments with the same or very close
score, no meaningful differentiation between the as-
signments can be made based on the score value only.
In this case the search engine is usually asked to
perform “clustering,”, that is, to assign the MS/MS
dataset to the protein already supported by the largest
number of other MS/MS spectra. This is a sensible
approach when a few abundant proteins are present in
the sample. However, such an ideal situation is rarely
met in real-life proteomics. In a more realistic case, there
is a great multitude of low-abundance proteins in the
sample. In such a situation, the “clustering” option
often forces the search engine to make a difficult
choice between assigning an MS/MS spectrum to a
protein with no other detected peptides or to a
protein with one low-scoring supporting peptide. The
statistical validity of the “clustering” approach be-
comes in that case rather questionable. The clustering
method may be responsible for the low overlap
758 ZUBAREV ET AL. J Am Soc Mass Spectrom 2008, 19, 753–761between the proteomes of the same biological system
measured by different labs [46].
Another side effect of clustering is underestimation
of the false discovery rate (FDR) when for the purpose
of FDR estimation both “forward” and “reversed” da-
tabases are concatenated into a single database. For
instance, matching the LC/MS/MS dataset from
Nielsen et al. [44] against a reversed NSBI database
gave 30 above-threshold hits. A subsequent search
using a forward database revealed that 29 of 30 pep-
tides also gave hits there. In 18 cases, the scores for the
forward and reverse assignments were the same. In one
of 18 cases, the sequence was palindromic, and thus
both forward and reverse assignments were correct.
The remaining 17 cases were expected to have statisti-
cally equal chances to be attributed to the forward and
reverse databases in a concatenated search. However, in
reality only two instead of the expected 8 to 9 peptides
were attributed to the reversed database, with 15 assigned
to forward sequences. Although the clustering function
responsible for attributing some of the “extra” peptides to
forward protein sequencing might have been right in
some cases, it is unlikely that all of the forward assign-
ments of same-score datasets were fully justified.
Another kind of MS/MS homology is when the
alternative second (or larger order) sequence assign-
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Figure 5. Distribution of the number of peptide sequences (not
necessarily unique) belonging to different proteins assigned by
Mascot with any score to each MS/MS dataset: (a) for search in the
full NCBI database; (b) for search against the human database. Ten
was the highest allowed number of sequences.ment to the same MS/MS spectrum receives a lowerscore than the best assignment, but which is still above
the threshold. In this situation there is a great tempta-
tion to believe the top-score assignment and ignore the
lower-scoring alternatives. The inevitable consequence
of this decision is the possibility that many assignments
received the top score not because they are correct but
simply because a better-scoring homolog was absent in
the database. One way to test the validity of the
received score is to compare it with an expected value
derived from an independently assigned parameter,
such as S-score [47], although even that method gives
no guarantee. It is thus more logical to accept as
“correct” all above-threshold sequence assignments,
thus acknowledging the very simple truth that in the
absence of complete MS/MS sequence information suf-
ficient for full de novo sequencing the best of what a
database search can establish is MS/MS homology and
not sequence identity.
The presence of peptide MS/MS homologs makes it
practically impossible to reach an error-free status in
peptide identification from incomplete MS/MS infor-
mation. On the idealized histogram of search-engine
score values reflecting the goodness of the fit, there are
two clearly separated distributions of the false positive
and true positive IDs (Figure 7a) [48]. In such a “hit or
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Figure 6. Distribution of the number of alternative peptide
sequences (zero means unique sequence) assigned by Mascot with
a top score above an automatically determined threshold value to
each MS/MS dataset: (a) for search in the full NCBI database; (b)
for search against the human database. Ten was the highest
allowed number of sequences.
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above which the assignments are considered reliable. In
reality, however, there is an intermediate distribution
(or rather, a distribution of distributions) of homolog hits
that make it impossible to set up a meaningful border
between the true hits from false positives (Figure 7b). At
every threshold value, some number of accepted hits
will be attributed to homolog peptides with sequences
different from those of the assigned ones.
Another artifact causing multiple alternative assign-
ments is the simultaneous selection for MS/MS of
Figure 7. Theoretical shapes of the distributions of search-engine
scores: (a) idealized “hit or miss” situation; (b) more realistic
situation taking into account the existence of homologs MS/MS
datasets.several peptides with similar m/z values, which canoccur when chromatographic resolution is insufficient
and many peptides elute at the same time. We will not
consider this problem in detail here, except for noting
that more extensive sequence information usually helps
to deal with it.
One possible solution to the MS/MS homology prob-
lem is relying not only on the absolute score of the best
sequence assignment to an MS/MS dataset, but also on
the score difference with the second-best assignment.
This approach is implemented in Sequest, XTandem,
new versions of Mascot (data on Figures 5 and 6 were
obtained with an older Mascot version), and possibly
other search engines. In this approach, if more than one
sequence from a database can be assigned to an MS/MS
spectrum, this assignment is not trusted. Although such
an approach definitely increases confidence in sequence
assignment, it cannot completely eliminate the homol-
ogy problem and, depending on the size of the data-
base, it can significantly limit the efficiency of a data-
base search. Indeed, according to Figure 6, 20 to 64% of
all MS/MS datasets with an above-threshold score are
not to be trusted. If the database included all possible
peptide sequences, few incomplete MS/MS datasets
could be assigned with certainty because almost every
incomplete dataset would be assignable to more than
one peptide sequence.
In our opinion, a more radical solution of the
MS/MS homology issue could be based not on disfa-
voring alternative assignments arising mostly because
of incompleteness of sequence information in MS/MS
datasets, but on elimination of this incompleteness
altogether. Such elimination is equivalent to the ability
of performing full de novo sequencing of every ana-
lyzed peptide. At the moment this is beyond the possi-
bility of mass spectrometry in routine analysis, but in
principle obtaining full sequence information on every
analyzed peptide is a realistic goal. One should bear in
mind, however, that even full de novo sequencing
leaves unsolved the sequence homology problem that
stems from the fact that many peptides, both tryptic
and nontryptic, are found in more than one protein
sequence.
Role of Mass Accuracy
Reliability of de novo sequencing is not an easy issue by
itself, and this topic is rarely discussed in the literature.
MS/MS sequencing has scored rather poorly in a recent
ABRF study where none of 106 participating laborato-
ries could correctly sequence all five nontryptic peptides
[49]. In our opinion, the reason for that poor performance
is not the design of de novo algorithms, but the insuffi-
cient quality of mass spectrometry data, given that the
truly high-performance de novo sequencing procedure
with 95% reliability demands a combination of two
complementary fragmentation techniques with ppm
molecular mass accuracy and fragment mass accuracy of
better than about 20 mDa [16]. The attempts to achieve
the 95% reliability target using low-resolution CxD data
760 ZUBAREV ET AL. J Am Soc Mass Spectrom 2008, 19, 753–761have so far been futile even when most sophisticated de
novo sequencing methods have been recruited. For
instance, the approach that uses several independently
acquired CxD MS/MS spectra of the same or slightly
modified sequence produced on average 50 hexapep-
tide sequence tags per spectrum, with only 82% prob-
ability of at least one tag to be correct [50]. Thus even
sequence tag identification is not reliable enough if data
are obtained with a low-resolution and single fragmen-
tation technique. In contrast to that, a Reliable Sequence
Tag (RST) derived from high-resolution CxD  ExD
data is more than 98% correct [16, 47]. For more on the
benefits of mass accuracy see Zubarev and Mann [51].
How to Combine CxD and ExD
Combination of data from two complementary fragmen-
tation techniques in one datafile can be done as described
in Nielsen et al. [44]. An even better alternative would be
to submit to database search twoMS/MS spectra “as is.”
Unfortunately, none of the existing search engines can,
to the best of our knowledge, accept such information
today. The informational content of side-chain losses,
which are abundant in both techniques [18, 40, 52], is
still underutilized by search engines, especially ExD
losses [40].
Conclusions
In this work we make a case for the combined use of
ExD and CxD techniques in tandem mass spectrometry
applied to shotgun proteomics. We argue that the only
way to reliably identify peptide sequences is through de
novo sequencing, which is achievable with desired
95% reliability only by using two complementary
fragmentation techniques and high mass accuracy. Thus
the answer to the question expressed in the title is: duet,
and duet only.
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